, Tracking Stock Market Picks
Enter Symbol:
Viropharma Incorporated (VPHM) [hlAlert]

up 848.00 %

Viropharma Incorporated (VPHM) rated Buy by ThinkEquity

Posted on: Thursday,  Oct 29, 2009  8:25 AM ET by ThinkEquity

ThinkEquity rated Buy Viropharma Incorporated (NASDAQ: VPHM) on 10/29/2009. Previously ThinkEquity rated Buy Viropharma Incorporated (NASDAQ: VPHM) on 04/28/2009., when
the stock price was $5.27. Since then, Viropharma Incorporated has gained 848.01% as of 01/23/2014's recent price of $49.96.
If you would have followed the previous ThinkEquity's recommendation on VPHM, you would have gained 848% of your investment in 1731 days.

VIROPHARMA is a leader in RNA virology and RNA antiviral drug discovery and development. The company is committed to the commercialization, development and discovery of antiviral pharmaceuticals. The company focuses on drug development and discovery activities for viral diseases including viral meningitis, viral respiratory infection, pneumonia, hepatitis C and influenza. Each year, a majority of the world's population is afflicted by at least one of these diseases, and antiviral therapies are either inadequate or do not exist.

Research is at the core of everything we do at ThinkEquity, and we're passionate about it. Employing a disciplined and rigorous process, we scrutinize the spectrum of forces at play in the growth sectors we cover. Starting with a top down analysis, we look closely at the megatrends and industry drivers that create opportunities for innovative companies. We then allocate our resources based on a long-range research roadmap that leads to deep domain expertise and a close working knowledge of the technologies, products, services and people that populate the growth sector landscape. In short, the sum result of the ThinkEquity research process is to identify and affiliate ourselves with the fastest growing private and public companies within our domain verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/29/2009 8:25 AM Buy
as of 12/31/2009
1 Week up  98.21 %
1 Month up  120.76 %
3 Months up  73.49 %
1 YTD up  110.46 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/28/2009 8:25 AM Buy
5.27 7.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy